These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 21777149

  • 1. Low-dose and very low-dose spironolactone in combination therapy for essential hypertension: evaluation by self-measurement of blood pressure at home.
    Hanazawa T, Obara T, Ogasawara K, Shinki T, Katada S, Inoue R, Metoki H, Asayama K, Kikuya M, Ohkubo T, Mano N, Imai Y.
    Clin Exp Hypertens; 2011; 33(7):427-36. PubMed ID: 21777149
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of combination antihypertensive therapy with low-dose indapamide: assessment by blood pressure self-monitoring at home.
    Hashimoto J, Hirayama H, Hanasawa T, Watabe D, Asayama K, Metoki H, Kikuya M, Ohkubo T, Totsune K, Imai Y.
    Clin Exp Hypertens; 2005 May; 27(4):331-41. PubMed ID: 15921070
    [Abstract] [Full Text] [Related]

  • 3. Differential impact of angiotensin receptor blockers and calcium channel blockers on arterial stiffness.
    Andreadis EA, Sfakianakis ME, Tsourous GI, Georgiopoulos DX, Fragouli EG, Katsanou PM, Tavoularis EI, Skarlatou MG, Marakomichelakis GE, Ifanti GK, Diamantopoulos EJ.
    Int Angiol; 2010 Jun; 29(3):266-72. PubMed ID: 20502415
    [Abstract] [Full Text] [Related]

  • 4. High-dose monotherapy vs low-dose combination therapy of calcium channel blockers and angiotensin receptor blockers in mild to moderate hypertension.
    Andreadis EA, Tsourous GI, Marakomichelakis GE, Katsanou PM, Fotia ME, Vassilopoulos CV, Diamantopoulos EJ.
    J Hum Hypertens; 2005 Jun; 19(6):491-6. PubMed ID: 15759025
    [Abstract] [Full Text] [Related]

  • 5. Spironolactone and chlorthalidone in uncontrolled elderly hypertensive patients treated with calcium antagonists and angiotensin II receptor-blocker: effects on endothelial function, inflammation, and oxidative stress.
    Yamanari H, Nakamura K, Miura D, Yamanari S, Ohe T.
    Clin Exp Hypertens; 2009 Oct; 31(7):585-94. PubMed ID: 19886856
    [Abstract] [Full Text] [Related]

  • 6. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y, Tsuchihashi T, Onaka U, Eto K, Ueno M.
    Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
    [Abstract] [Full Text] [Related]

  • 7. Comparison of effects of low dose of spironolactone and a thiazide diuretic in patients with hypertension treated with an angiotensin-converting enzyme inhibitor or an angiotensin type 1 receptor blocker.
    Yutaka M, Mifune M, Kubota E, Itoh H, Saito I.
    Clin Exp Hypertens; 2009 Nov; 31(8):648-56. PubMed ID: 20001457
    [Abstract] [Full Text] [Related]

  • 8. [Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients].
    Hanon O, Laroche P, Vidal JS, Pannier B, Postel-Vinay N, Vaisse B, Girerd X.
    Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):218-23. PubMed ID: 22695025
    [Abstract] [Full Text] [Related]

  • 9. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ, Ishola DA, Akintomide AO, Ajayi AA.
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [Abstract] [Full Text] [Related]

  • 10. Current status of antihypertensive prescription and associated blood pressure control in Japan.
    Mori H, Ukai H, Yamamoto H, Saitou S, Hirao K, Yamauchi M, Umemura S.
    Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149
    [Abstract] [Full Text] [Related]

  • 11. [Renoprotective effect of triple therapy with low-dose angiotensin receptor blocker, low-dose diuretic and Ca-antagonist in hypertensive type 2 diabetic patients with overt nephropathy].
    Kuriyama S, Tomonari H, Ohtsuka Y, Ohkido I, Hosoya T.
    Nihon Jinzo Gakkai Shi; 2003 Mar; 45(4):367-71. PubMed ID: 12806973
    [Abstract] [Full Text] [Related]

  • 12. The role of fixed-dose combination therapy with drugs that target the renin-angiotensin system in the hypertension paradigm.
    Schmieder RE.
    Clin Exp Hypertens; 2010 Jan; 32(1):35-42. PubMed ID: 20144071
    [Abstract] [Full Text] [Related]

  • 13. Additional antihypertensive effect of drugs in hypertensive subjects uncontrolled on diltiazem monotherapy: a randomized controlled trial using office and home blood pressure monitoring.
    Karotsis AK, Symeonidis A, Mastorantonakis SE, Stergiou GS, Home-Di-Plus Study Group.
    Clin Exp Hypertens; 2006 Oct; 28(7):655-62. PubMed ID: 17060064
    [Abstract] [Full Text] [Related]

  • 14. Switching therapy to bedtime for uncontrolled hypertension with a nondipping pattern: a prospective randomized-controlled study.
    Farah R, Makhoul N, Arraf Z, Khamisy-Farah R.
    Blood Press Monit; 2013 Aug; 18(4):227-31. PubMed ID: 23660686
    [Abstract] [Full Text] [Related]

  • 15. [Perfect 24-hr blood pressure control using self-measured blood pressure and ambulatory blood pressure monitoring in chronic kidney disease].
    Kario K.
    Nihon Jinzo Gakkai Shi; 2009 Aug; 51(4):465-70. PubMed ID: 19601555
    [No Abstract] [Full Text] [Related]

  • 16. Blood pressure and serum potassium levels in hypertensive patients receiving or not receiving antihypertensive treatment.
    Pikilidou MI, Lasaridis AN, Sarafidis PA, Tziolas IM, Zebekakis PE, Dombros NV, Giannoulis E.
    Clin Exp Hypertens; 2007 Nov; 29(8):563-73. PubMed ID: 18058481
    [Abstract] [Full Text] [Related]

  • 17. [Antihypertensive therapy for refractory morning hypertension in patients on peritoneal dialysis].
    Kuriyama S, Otsuka Y, Iida R, Kobayashi S, Yamagishi H, Hosoya T.
    Nihon Jinzo Gakkai Shi; 2005 Nov; 47(1):38-45. PubMed ID: 15754762
    [Abstract] [Full Text] [Related]

  • 18. Blood pressure and metabolic effect of a combination of lercanidipine with different antihypertensive drugs in clinical practice.
    Cicero AF, Gerocarni B, Rosticci M, Borghi C.
    Clin Exp Hypertens; 2012 Nov; 34(2):113-7. PubMed ID: 21967031
    [Abstract] [Full Text] [Related]

  • 19. Amiloride 10 mg is less effective than spironolactone 25 mg in patients with hypertension resistant to a multidrug regime including an angiotensin-blocking agent.
    Lane DA, Beevers DG.
    J Hypertens; 2007 Dec; 25(12):2515-6. PubMed ID: 17984678
    [No Abstract] [Full Text] [Related]

  • 20. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
    Jamerson KA, Nwose O, Jean-Louis L, Schofield L, Purkayastha D, Baron M.
    Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.